SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, highlighted in multiple breakout sessions, and used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in multiple sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries, while approximately 2,100 physicians have been trained on the platform.
The demonstration of a remote partial nephrectomy is particularly significant as it showcases the potential for telesurgery to bridge geographic gaps in surgical expertise. The ability to perform complex procedures like a partial nephrectomy from thousands of miles away could revolutionize access to specialized care, especially for patients in underserved regions. This aligns with SS Innovations' mission to make robotic surgery affordable and accessible globally. For more details on the announcement, visit https://ibn.fm/YYYKE.
SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
The company’s participation at the Society of Robotic Surgery Annual Meeting is a key opportunity to engage with industry leaders, discuss regulatory frameworks for telesurgery, and highlight the growing adoption of robotic surgery worldwide. With over 12,000 procedures performed and a wide range of surgical applications, SSi Mantra is positioned as a versatile platform that could lower barriers to robotic surgery adoption. The focus on telesurgery also addresses a critical need for remote surgical capabilities, which has gained urgency in the wake of global health challenges and the push for healthcare equity.
